This trial is evaluating whether Treatment will improve 1 primary outcome and 5 secondary outcomes in patients with Multimodal Analgesic Approach. Measurement will happen over the course of Postoperative.

6 months Postoperative

Long Term Opioid Usage

Month 6

Visual Analog Scale (VAS) for back and legs

Immediate postoperative

Length of Stay (LOS)

Time to Ambulation

Postoperative

Opioid Equivalent Dosing during Hospital Stay

Month 6

Oswestry Disability Index Version 2.1 (ODI)

Trial Safety

Safety Progress

3 of 3

This is further along than 85% of similar trials

Other trials for Multimodal Analgesic Approach

1

Novel rTMS Approach

1

EHR-Based Approach

2

Analgesic Non Narcotic

Trial Design

2 Treatment Groups

PO Acetaminophen

1 of 2

Intravenous Acetaminophen

1 of 2

Active Control

This trial requires 166 total participants across 2 different treatment groups

This trial involves 2 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are in Phase 4 and have been shown to be safe and effective in humans.

PO Acetaminophen

Drug

Preop: Eligible patients will receive oral acetaminophen within 3 hours of OR start time. Postop: Eligible patients will be administered oral acetaminophen following 1 and 2 level LLIFs supplemented with instrumented posterior fusion to evaluate pain management outcomes. Dosing for the group will be the following: • Oral Acetaminophen 1,000 mg every 6 hours for 48 hours postoperative. Medication will be given at least 6 hours following initial preoperative dose of oral acetaminophen. Postop supplemental pain medications: All patients will receive a standardized hydromorphone IV-PCA order set for 24 hours postoperatively. The use of tramadol and tapentadol will specifically be discouraged due to challenges in determining morphine-equivalent dosing with these specific agents. Similarly, acetaminophen containing combination products (e.g. oxycodone/acetaminophen or hydrocodone/acetaminophen) will not be allowed due to overlap with the primary study medications.

Intravenous Acetaminophen

Drug

Preop: Eligible patients will receive IV acetaminophen within 3 hours of OR start time. Postop: Eligible patients will be administered IV acetaminophen following 1 and 2 level LLIFs supplemented with instrumented posterior fusion to evaluate pain management outcomes. Dosing for the group will be the following: • IV Acetaminophen 1,000 mg [100 ml] every 6 hours for 48 hours postoperative. Medication will be given at least 6 hours following initial preoperative dose of IV acetaminophen. Postop supplemental pain medications: All patients will receive a standardized hydromorphone IV-PCA order set for 24 hours postoperatively. The use of tramadol and tapentadol will specifically be discouraged due to challenges in determining morphine-equivalent dosing with these specific agents. Similarly, acetaminophen containing combination products (e.g. oxycodone/acetaminophen or hydrocodone/acetaminophen) will not be allowed due to overlap with the primary study medications.

Trial Logistics

Trial Timeline

Approximate Timeline

Screening: ~3 weeks

Treatment: Varies

Reporting: preoperative, 6 weeks and 6 months postoperative

This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly preoperative, 6 weeks and 6 months postoperative for reporting.

Closest Location

Hospital for Special Surgery - New York, NY

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 6 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:

Diagnosis of spinal stenosis of the lumbar spine with degenerative spondylolisthesis

Skeletally mature adults between the ages of 18-85 years at the time of surgery

The greater of the patients right and left VAS leg pain, or back pain, score is > 40 mm on a 100 mm scale

Has attempted conservative therapy

Psychosocially, mentally, and physically able to fully comply with this protocol, including adhering to scheduled visits, treatment plan, completing forms, and other study procedures

Personally signed and dated informed consent document prior to any study-related procedures indicating that the patient has been informed of all pertinent aspects of the study

Patient Q&A Section

Ask a question about the study

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial

Get access to this novel treatment for Multimodal Analgesic Approach by sharing your contact details with the study coordinator.

Treatment for Multimodal Analgesic Approach

Study Summary

IV vs Oral Acetaminophen in Spine Fusion Perioperative Care

Treatment Effectiveness

Effectiveness Progress

Other trials for Multimodal Analgesic Approach

Study Objectives

Trial Safety

Safety Progress

Other trials for Multimodal Analgesic Approach

Trial Design

2 Treatment Groups

PO Acetaminophen

1 of 2

Intravenous Acetaminophen

1 of 2

Trial Logistics

Trial Timeline

Closest Location

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 6 eligibility criteria to participate in this trial as listed below.

Patient Q&A Section

Ask a question about the study

Other questions from users

Are there any geographic restrictions to consider when applying for this trial?

Will my insurance cover participating in this trial?

Other Trials to Consider

Novel RTMS Approachfor Stroke

EHR-Based Approachfor Medication Dosing Error

Analgesic Non Narcoticfor Pain, Postoperative

Multimodal Optical Imagingfor Cervical Cancers

Acetaminophen And Ibuprofenfor Humeral Fractures

NSAIDsfor Traumas

Parent Interactive Text Message - Benefits Approachfor HPV

Acetaminophenfor Fear

Multimodal Prehabilitationfor Prehabilitation

Multimodal Therapeutic Warming W/ Esophageal D/cfor Pyemia

Multimodal Lifestyle Programfor Neoplasms, Malignant

Multimodal Intervention Consisting Of Four Core Componentsfor Inflammatory Bowel Diseases

Popular Categories

Top 10 Narcolepsy Clinical Trials

Top 10 Atopic Dermatitis Clinical Trials

Top 10 Scoliosis Clinical Trials

Top 10 Aricept Clinical Trials

Best 10 Miami Clinical Trials

Best 10 Austin Clinical Trials

Best 10 Dallas Clinical Trials

Best 10 Meridian Clinical Trials

Best 10 Minneapolis Clinical Trials

Best 10 Sacramento Clinical Trials

Best 10 Glendale Clinical Trials

Best 10 Milwaukee Clinical Trials

Top 10 CBD Clinical Trials

Top 10 Parkinsons Clinical Trials

Best 10 Edmonton Clinical Trials

Popular Clinical Trials

Top Clinical Trials in Cities

Relevant Clinical Trials